Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Phase III results with Lilly's raloxifene reported

June 6, 1997

r-metHuSCF + filgrastrim for PBPC mobilization and transplantation: a phase I/II trial

June 6, 1997

Fujisawa discloses agents for bone metabolism disorders

June 6, 1997

Didronel PMO approved for prevention of osteoporosis in U.K.

June 5, 1997

Cholesterol-lowering activity of squalene synthase inhibitor in animal models

June 5, 1997

Focus on drug interactions with a common food: grapefruit

June 5, 1997

Shaman issued U.S. patents for type II diabetes compounds

June 4, 1997

U. of California discloses mammalian EPO-BP

June 4, 1997

ACE inhibitors inhibit bone resorption in vitro

June 3, 1997

AGE inhibitor described by Kissei

June 3, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...